Health Category

Digestive Health & Clinical Nutrition Guides & Resources

Evidence-based gastroenterology guides, gut microbiome science, GERD, IBS, intermittent fasting, and exercise physiology.

Articles in Digestive Health & Clinical Nutrition (33)

View all articles
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) diagnostic ultrasound scan and medical consultationHeart & Cardiometabolic Health
2026-10-18 1437

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Stages, SGPT/ALT Tests, FibroScan, and Evidence-Based Dietary Reversal

A comprehensive clinical roadmap to understanding and reversing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Covers hepatic fat accumulation, elevated ALT/SGPT interpretation, FibroScan CAP scores, insulin resistance, and an actionable evidence-based dietary plan.

Managing Blood Pressure Naturally: Evidence-Based Clinical Strategies & DASH ProtocolsHeart & Cardiometabolic Health
2026-09-24 5310

Managing Blood Pressure Naturally: Evidence-Based Clinical Strategies & DASH Protocols

Hypertension (BP ≥ 130/80 mmHg) is the single most modifiable risk factor for stroke, myocardial infarction and chronic kidney disease. Understand the physiological processes that result in lowering blood pressure without medication, including the DASH diet, salt/potassium balance, isometric training and autonomic modulation of stress.

Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission ProtocolsHeart & Cardiometabolic Health
2026-09-14 4950

Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission Protocols

Type 2 Diabetes is a progressive metabolic disease that causes insulin resistance in peripheral tissues and progressive dysfunction of pancreatic β cells. This article will discuss the current diagnostic criteria set forth by the American Diabetes Association (ADA), modern cardioprotective therapies such as GLP-1 RA and SGLT2 inhibitors, as well as Continuous Glucose Monitoring (CGM) and diabetes remission therapies.

Irritable Bowel Syndrome (IBS): Subtypes, Visceral Hypersensitivity, and Low-FODMAP DietDigestive Health & Clinical Nutrition
2026-09-12 2122

Irritable Bowel Syndrome (IBS): Subtypes, Visceral Hypersensitivity, and Low-FODMAP Diet

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (FGBI) that affects around 10% of the world population and causes recurring abdominal discomfort with changes to bowel habits. The Rome IV criteria will be reviewed, along with specific sub-types of IBS (IBS-C, IBS-D, IBS-M). Visceral hypersensitivity will be discussed alongside Small Intestinal Bacterial Overgrowth (SIBO), and finally the 3 phase low-FODMAP elimination and challenge protocol.

Benign Prostatic Hyperplasia (BPH): IPSS Score, PSA Testing, and Urinary ManagementSenior Healthcare & Longevity
2026-09-12 1681

Benign Prostatic Hyperplasia (BPH): IPSS Score, PSA Testing, and Urinary Management

Background: Benign prostatic hyperplasia refers to a benign adenomatous proliferation of the transition zone within the prostate. This affects >70% of men over the age of 60 years. Describe the presentation of obstructive / irritative lower urinary tract symptoms. Describe the scoring system (IPSS), assessment of PSA levels, management with alpha-1 blockers, 5-alpha reductase inhibitors and minimally invasive surgical interventions.

Chronic Kidney Disease (CKD): Stages, eGFR Decline, Potassium, and Renal NutritionSenior Healthcare & Longevity
2026-09-11 1980

Chronic Kidney Disease (CKD): Stages, eGFR Decline, Potassium, and Renal Nutrition

Chronic Kidney Disease describes progressive irreversible kidney damage over a period of more than 3 months. There are 5 stages of CKD according to the estimated Glomerular Filtration Rate (eGFR) and the levels of albuminuria. This section will cover KDIGO staging heatmaps, metabolic complications e.g. hyperkalemia, hyperphosphatemia & renal anaemia and renal specific medical nutrition therapy.

Intermittent Fasting & Autophagy: 16/8 Protocols, Cellular Cleansing, and Metabolic HealthDigestive Health & Clinical Nutrition
2026-09-10 2390

Intermittent Fasting & Autophagy: 16/8 Protocols, Cellular Cleansing, and Metabolic Health

Time Restricted Eating (TRE) and intermittent fasting will teach you how to switch your body away from being on a constant intake of nutrients using mTOR, into a state of cellular maintenance & repair using AMPK activation and autophagy. Learn how to get your body to switch from Glucose to Ketones, sensitize your insulin receptors, understand how Autophagy works plus how to fit a 16/8 eating window.

Obstructive Sleep Apnea (OSA): STOP-Bang Screening, CPAP Therapy, and Heart HealthMental Health & Sleep Science
2026-09-08 2150

Obstructive Sleep Apnea (OSA): STOP-Bang Screening, CPAP Therapy, and Heart Health

An obstructive sleep apnea (OSA) is a chronic breathing disorder that occurs during sleep. It results in repeated obstruction of the upper respiratory tract causing desaturation, increased sympathetic activation and disrupted sleep at night. Describe the STOP-Bang tool, levels of severity of OSA (based on AHI), CPAP adherence and the cardiovascular consequences (hypertension, AFib, stroke).

Hypothyroidism and Hashimoto's Thyroiditis: TSH, Free T4, TPO Antibodies, and LevothyroxineWomen's & Hormonal Health
2026-09-08 2280

Hypothyroidism and Hashimoto's Thyroiditis: TSH, Free T4, TPO Antibodies, and Levothyroxine

Hashimoto's thyroiditis is the most common cause of primary hypothyroidism in females and is due to an autoimmune destruction of thyroid follicular cells. This question will cover some laboratory findings to consider when diagnosing the condition, appropriate levothyroxine dosing, common factors which hinder absorption and diet.

Coronary Artery Disease: Warning Signs, Risk Factors, and Medical ManagementHeart & Cardiometabolic Health
2026-09-04 4820

Coronary Artery Disease: Warning Signs, Risk Factors, and Medical Management

Coronary Artery Disease (CAD) is the leading cause of mortality globally, caused by atherosclerotic plaque build up in the epicardial coronary arteries. This section covers current diagnostic modalities such as coronary artery calcium scoring and CT coronary angiography plus current medical therapy including high intensity statins, beta blockers & ACE inhibitors. Indications for revascularisation are also discussed.

Migraine vs. Tension Headache: Aura, CGRP Pathway, Triggers, and Abortive TreatmentsMental Health & Sleep Science
2026-09-04 2010

Migraine vs. Tension Headache: Aura, CGRP Pathway, Triggers, and Abortive Treatments

Headache is one of the most common neurological complaints and often leads to overuse of medications when migraines are misdiagnosed as tension headaches. This review will look at the pathophysiology of the trigeminovascular system, sensory aura mechanisms, diagnostic criteria (ICHD-3), acute abortive medications (triptans/gepants) and current CGRP monoclonal antibody therapies.

Atrial Fibrillation (AFib): Symptoms, Stroke Risks, and Rate Control StrategiesHeart & Cardiometabolic Health
2026-09-02 4610

Atrial Fibrillation (AFib): Symptoms, Stroke Risks, and Rate Control Strategies

Atrial Fibrillation (AFib) is the most common chronic cardiac arrhythmia. It causes irregular and rapid electrical impulses (300-600bpm) in the atria. Understand how stroke risk can be assessed, using the CHA2DS2-VASc scoring system. Recognise the role of modern Direct Oral Anticoagulants (DOACs). Understand how rate and rhythm control can be achieved. Know about catheter ablation to isolate pulmonary veins.

Heart Failure with Preserved Ejection Fraction (HFpEF): Symptoms, Stiff Heart Muscle, and TreatmentHeart & Cardiometabolic Health
2026-09-02 1840

Heart Failure with Preserved Ejection Fraction (HFpEF): Symptoms, Stiff Heart Muscle, and Treatment

Heart failure with preserved ejection fraction (HFpEF) is a condition characterised by left ventricular hypertrophy or stiffness. This prevents appropriate filling of the heart during diastole. It can be diagnosed using biomarkers such as NT-proBNP and echocardiography e’/E ratios. Patients can also be managed with evidence based therapies such as SGLT2 inhibitors and blood pressure control.

High Cholesterol (Hyperlipidemia): Understanding Lipid Panels, Statin Therapy, and DietHeart & Cardiometabolic Health
2026-08-31 4720

High Cholesterol (Hyperlipidemia): Understanding Lipid Panels, Statin Therapy, and Diet

Atherogenic dyslipidaemia is a primary modifiable risk factor in atherosclerotic cardiovascular disease. This lecture will provide an overview of contemporary lipidology, including Apo B, non-HDL cholesterol, Lipoprotein(a), evidence based statin dosing algorithms, and novel non-statin therapies (e.g. Ezetimibe, PCSK9 inhibitors).

Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar ControlHeart & Cardiometabolic Health
2026-08-27 4410

Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar Control

Diabetic Peripheral Neuropathy (DPN) is the most common chronic microvascular complication of diabetes affecting up to 50% of diabetic patients over the course of their life. This essay will explore the biochemical pathways involved in neural glucotoxicity (polyol pathway and accumulation of sorbitol, and microvascular vasa nervorum ischemia), clinical testing using 10-g Semmes-Weinstein monofilaments, and pharmacological treatment for pain.

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency CareHeart & Cardiometabolic Health
2026-08-25 4590

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency Care

Hypoglycaemia (< 70mg/dL blood sugar) is a potentially life threatening acute endocrine emergency often seen in patients on insulin or sulfonylureas. This article will discuss the neuroendocrine effects of decreasing blood sugar, the difference between autonomic and neuroglycopenic symptoms, the standardised clinical approach known as The Rule of 15 and emergency glucagon rescue.

GERD and Chronic Acid Reflux: Triggers, PPI Medications, and Dietary AdjustmentsDigestive Health & Clinical Nutrition
2026-08-23 4720

GERD and Chronic Acid Reflux: Triggers, PPI Medications, and Dietary Adjustments

Gastroesophageal reflux disease (GERD) is a chronic digestive disorder caused by the backflow of gastric acid into the esophagus causing inflammation. This can cause uncomfortable symptoms. Investigate the biomechanics of Lower Esophageal Sphincter dysfunction. Evaluate how step-up and step-down treatment therapies (PPIs and H2 blockers) are used. Consider endoscopic screening for Barrett's esophagus and clinical dietetic interventions.

Gout and Hyperuricemia: Uric Acid Causes, Flare-Up Relief, and Low-Purine DietDigestive Health & Clinical Nutrition
2026-08-21 4520

Gout and Hyperuricemia: Uric Acid Causes, Flare-Up Relief, and Low-Purine Diet

Gout is a severely painful crystalline arthropathy caused by MSU crystal deposition in synovial joints and tissues. Explore the metabolic processes involved in purine metabolism, factors that cause hyperuricemia (>6.8 mg/dL), agents used to treat acute attacks (Colchicine/NSAID). And long-term therapy using Urate Lowering drug (Allopurinol) to target levels.

Metabolic Syndrome: Clinical Diagnostic Criteria, Heart Risks, and Lifestyle ReversalHeart & Cardiometabolic Health
2026-08-19 4810

Metabolic Syndrome: Clinical Diagnostic Criteria, Heart Risks, and Lifestyle Reversal

Metabolic Syndrome is a cluster of inter-related abnormalities that greatly increases the risk of developing cardiovascular disease, type 2 diabetes and mortality. We will look at the standard diagnostic criteria for Metabolic Syndrome (NCEP ATP III), the pathophysiology of visceral adiposity and lipotoxicity and finally at the full range of lifestyle interventions available to reverse Metabolic Syndrome.

Polycystic Ovary Syndrome (PCOS): Symptoms, Hormone Imbalances, and ManagementWomen's & Hormonal Health
2026-08-17 4910

Polycystic Ovary Syndrome (PCOS): Symptoms, Hormone Imbalances, and Management

Polycystic ovary syndrome PCOS is the most common endocrine and metabolic disorder affecting women of reproductive age worldwide (8-13%). We will discuss the Rotterdam criteria for diagnosis, pathophysiological mechanisms of hyperandrogenism and hyperinsulinism, evidence based dietary interventions (myo-inositol, low GI diets) and inducing ovulation.

Endometriosis: Chronic Pelvic Pain, Laparoscopy Diagnosis, and Medical TherapiesWomen's & Hormonal Health
2026-08-15 4720

Endometriosis: Chronic Pelvic Pain, Laparoscopy Diagnosis, and Medical Therapies

Endometriosis is a chronic estrogen dependant inflammatory disease with presence of endometrium like glands and stroma outside the uterus. Discuss the pathophysiology behind retrograde menstruation and coelomic metaplasia. Describe investigations such as expert ultrasound, MRI and laparoscopic excision with histology. Describe the use of hormonal suppression and surgical excision.

Perimenopause and Menopause: Vasomotor Symptoms, Mood Changes, and HRT EvidenceWomen's & Hormonal Health
2026-08-13 4890

Perimenopause and Menopause: Vasomotor Symptoms, Mood Changes, and HRT Evidence

Describe the neuro-endocrine changes during menopause including variable ovarian follicular pool, reduced estradiol and increased pituitary gonadotrophins (FSH). Include a clinical perspective of the transition from perimenopause to surgical and natural menopause, reduced vasomotor temperature range, current transdermal MHT (HRT), non-hormonal options.

Major Depressive Disorder (MDD): Clinical Symptoms, Neurotransmitters, and TherapyMental Health & Sleep Science
2026-08-11 4890

Major Depressive Disorder (MDD): Clinical Symptoms, Neurotransmitters, and Therapy

The major depressive disorder (MDD) is a debilitating neuropsychiatric condition involving persistent depressive symptoms, anhedonia and cognitive-affective dysfunction. This essay will explore the current neurobiological mechanisms involved in MDD such as neuroinflammation, HPA axis dysfunction, synaptic atrophy due to BDNF, and evidence based psychological therapy.

Adult ADHD: Diagnostic Symptoms, Executive Dysfunction, and Daily Coping StrategiesMental Health & Sleep Science
2026-08-09 4720

Adult ADHD: Diagnostic Symptoms, Executive Dysfunction, and Daily Coping Strategies

Attention-Deficit/Hyperactivity Disorder (ADHD) is a complex neurodevelopmental disorder of the executive functioning system of the brain. It affects around 4-5% of the adult population. This article will look at the neurobiology of the prefrontal dopaminergic and noradrenergic systems, symptoms of ADHD related executive dysfunction in adults, and diagnostic assessments (ASRS v1.1). As well as medical and behavioural treatments.

Osteoporosis and Bone Mineral Density: DEXA Scans, Calcium, and Fall PreventionSenior Healthcare & Longevity
2026-07-30 4520

Osteoporosis and Bone Mineral Density: DEXA Scans, Calcium, and Fall Prevention

Describe osteoporosis. A skeletal system disease that leads to decreased bone mineral density. It also causes structural damage to the bones. This results into fragile bones, and increases the risk of fractures. Describe the cell biology of osteoclasts and osteoblasts. DEXA scans, T scores, FRAX, anti-resorptives and anabolic drugs used to treat bones, and progressive resistance exercises.

Early Signs of Dementia and Alzheimer's vs. Normal Age-Related Memory ChangesSenior Healthcare & Longevity
2026-07-28 4890

Early Signs of Dementia and Alzheimer's vs. Normal Age-Related Memory Changes

Outline the neurological features of dementia (progressive decline in cognition that affects independent function). Describe the pathological features of Alzheimer's Disease including extra-cellular amyloid beta plaques and intra-cellular hyper-phosphorylated tau neurofibrillary tangles, describe the tools used to screen for cognition (MoCA, Mini-Cog). Identify reversible causes of pseudo-dementia and discuss Monoclonal antibody treatments that alter the course of disease.

Cardio vs Strength Training: Optimizing Muscle Mass, Fat Loss, and Metabolic HealthDigestive Health & Clinical Nutrition
2026-07-13 4890

Cardio vs Strength Training: Optimizing Muscle Mass, Fat Loss, and Metabolic Health

In exercise science and metabolic health, the debate between aerobic endurance training (cardio) and progressive resistance training (strength) is often framed as an either/or dichotomy. In physiological reality, these two modalities stimulate complementary cellular signaling pathways (AMPK vs. mTORC1) that synergize to maximize metabolic flexibility, body composition, cardiorespiratory fitness, and all-cause longevity.

VO2 Max and Heart Rate Zones: How Aerobic Capacity Predicts Long-Term HealthDigestive Health & Clinical Nutrition
2026-07-11 4720

VO2 Max and Heart Rate Zones: How Aerobic Capacity Predicts Long-Term Health

Cardiorespiratory fitness, quantified objectively as VO2 Max (maximal oxygen uptake in mL/kg/min), is the single most powerful modifiable biomarker predicting all-cause mortality and cardiovascular healthspan. Explore the cardiopulmonary Fick equation, the physiological boundaries of 5-tier Heart Rate Training Zones, mitochondrial Zone-2 base building, and the Norwegian 4x4 HIIT protocol.

Circadian Rhythms and Sleep Architecture: Optimizing REM and Deep Sleep CyclesMental Health & Sleep Science
2026-07-09 4890

Circadian Rhythms and Sleep Architecture: Optimizing REM and Deep Sleep Cycles

Human sleep is orchestrated by two fundamental biological forces: the homeostatic sleep drive (Process S - adenosine accumulation) and the endogenous circadian clock (Process C - master suprachiasmatic nucleus pacemakers). Explore the cellular mechanics of sleep architecture, ultradian 90-minute cycling, the glymphatic waste clearance system, and circadian photobiology optimization protocols.